Trials / Completed
CompletedNCT01329783
EuroSIDA As An External Comparator To MOTIVATE Trials
Incidence And Risk Factors For Acquired Immune Deficiency Syndrome (AIDS) Defining And Non-AIDS Defining Malignancies, And Other AIDS Defining Illnesses In The EuroSIDA Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,181 (actual)
- Sponsor
- ViiV Healthcare · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
Human Immunodeficiency Virus (HIV) infected patients who meet the entry criteria for the maraviroc pivotal trials (Maraviroc versus Optimized Therapy in Viremic Antiretroviral Treatment-Experienced Patients, MOTIVATE) will be identified from the EuroSIDA HIV cohort. The rates of specific clinical adverse events in this identified patient population will be compared with the rates of these events in the participants of the MOTIVATE trials.
Detailed description
All patients in EuroSIDA cohort that meet the entry criteria of MOTIVATE trials are included without any sampling.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | maraviroc | No intervention is distributed during this trial. |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2011-04-06
- Last updated
- 2011-05-16
Source: ClinicalTrials.gov record NCT01329783. Inclusion in this directory is not an endorsement.